Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cells.

Cytosine arabinoside (Ara-C) is the most effective agent in the treatment of acute myelogenous leukemia. This agent incorporates in leukemic cell DNA, and the extent of this incorporation correlates with loss of clonogenic survival. The incorporated Ara-C residue behaves as a relative DNA chain terminator, and the extent of (Ara-C)DNA formation correlates with inhibition of DNA synthesis. The incorporation of Ara-C into DNA requires the formation of Ara-CTP, and previous measurements of this metabolite have also been correlated with cytotoxicity. Because it is clinically relevant to define biochemical parameters predictive of Ara-C cytotoxicity, the present studies were undertaken to determine the relationship among Ara-CTP pools, formation of (Ara-C)DNA, and loss of clonogenic survival. The results demonstrate that the incorporation of Ara-C into DNA is the single most powerful predictor of cell lethality. Furthermore, although there is a correlation between Ara-CTP pools or continuous cellular exposure to Ara-CTP and cell kill, these relationships are less significant than that obtained with formation of (Ara-C)DNA. The extent of Ara-C incorporation into DNA can be predicted by the product of the Ara-CTP level and time (T), thus supporting the concept that Ara-C incorporation is dependent on continuous exposure to the triphosphate metabolite. These findings support the formation of (Ara-C)DNA as a highly predictive parameter of lethal cellular events.

[1]  H. Krokan,et al.  Effect of 1-beta-D-arabinofuranosylcytosine triphosphate on DNA synthesis in isolated HeLa cell nuclei. , 1976, Biochemistry.

[2]  D. Woodcock,et al.  Evidence for double replication of chromosomal DNA segments as a general consequence of DNA replication inhibition. , 1981, Cancer research.

[3]  D. Kufe,et al.  Correlation of cytotoxicity with incorporation of ara-C into DNA. , 1980, The Journal of biological chemistry.

[4]  C. Gresham,et al.  Inhibition of DNA synthesis but not of poly-dAT synthesis by the arabinose analogue of cytidine in vitro. , 1971, Nature: New biology.

[5]  J. Griffin,et al.  Induction of differentiation of human myeloid leukemia cells by inhibitors of DNA synthesis. , 1982, Experimental hematology.

[6]  H. Preisler,et al.  Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy. , 1979, Cancer research.

[7]  S. Cohen,et al.  Introduction to the biochemistry of D-arabinosyl nucleosides. , 1966, Progress in nucleic acid research and molecular biology.

[8]  J. Burchenal,et al.  Treatment of acute leukemia in adults , 1975, Cancer.

[9]  R. Momparler.  Biochemical pharmacology of cytosine arabinoside. , 1982, Medical and pediatric oncology.

[10]  A. Fridland.  Effect of cytosine arabinoside on replicon initiation in human lymphoblasts. , 1977, Biochemical and biophysical research communications.

[11]  W. Benedict,et al.  The effect of 1-beta-D-arabinofuranosylcytosine on cell viability, DNA synthesis, and chromatid breakage in synchronized hamster fibrosarcoma cells. , 1976, Cancer research.

[12]  Y. Rustum.  Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors. , 1978, Cancer research.

[13]  W. Benedict,et al.  Chromatid Breakage: Differential Effect of Inhibitors of DNA Synthesis during G2 Phase , 1972, Science.

[14]  N. Cozzarelli.  The mechanism of action of inhibitors of DNA synthesis. , 1977, Annual review of biochemistry.

[15]  J. Furth,et al.  Inhibition of Mammalian DNA Polymerase by the 5′-Triphosphate of 1-β-d-Arabinofuranosylcytosine and the 5′-Triphosphate of 9-β-d-Arabinofuranosyladenine , 1968 .

[16]  Burns Cp,et al.  Cytosine arabinoside as a single agent in the therapy of adult acute leukemia. , 1974 .

[17]  P. Roy‐Burman.  Analogues of Nucleic Acid Components , 1970, Recent Results in Cancer Research.

[18]  J. Bickers,et al.  Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). , 1969, Cancer research.

[19]  A. Fridland.  Inhibition of deoxyribonucleic acid chain initiation: a new mode of action for 1-beta-D-arabinofuranosylcytosine in human lymphoblasts. , 1977, Biochemistry.